Dymicron, the company developing the Triadyme-C cervical disc, added Peter Wehrly to its board of directors, according to a Feb. 19 news release.
Mr. Wehrly has extensive experience in the medtech industry including president of Premia Spine’s U.S. business, CEO of Vivex Biologics and multiple leadership roles within Medtronic.
“Dymicron’s Triadyme-C technology represents a true leap forward in motion preservation, combining advanced biomechanics with a bearing surface that addresses longstanding wear-debris challenges in cervical arthroplasty,” he said in the release. “The company’s commitment to rigorous clinical validation and global commercialization strongly aligns with my professional focus. I look forward to supporting the leadership team as Dymicron advances toward PMA approval and broadens its global impact.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
